Literature DB >> 15964982

The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.

Kailash C Pandey1, Stephanie X Wang, Puran S Sijwali, Anthony L Lau, James H McKerrow, Philip J Rosenthal.   

Abstract

Falcipain-2 (FP2) is a papain family cysteine protease and important hemoglobinase of erythrocytic Plasmodium falciparum parasites. Inhibitors of FP2 block hemoglobin hydrolysis and parasite development, suggesting that this enzyme is a promising target for antimalarial chemotherapy. FP2 and related plasmodial cysteine proteases have an unusual 14-aa motif near the C terminus of the catalytic domain. Recent solution of the structure of FP2 showed this motif to form a beta-hairpin that is distant from the enzyme active site and protrudes out from the protein. To evaluate the function of this motif, we compared the activity of the wild-type enzyme with that of a mutant lacking 10 aa of the motif (Delta10FP2). Delta10FP2 had nearly identical activity to that of the wild-type enzyme against peptide substrates and the protein substrates casein and gelatin. However, Delta10FP2 demonstrated negligible activity against hemoglobin or globin. FP2 that was inhibited with trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (FP2E-64) formed a complex with hemoglobin, but Delta10FP2E-64 did not, indicating that the motif mediates binding to hemoglobin independent of the active site. A peptide encoding the motif blocked hemoglobin hydrolysis, but not the hydrolysis of casein. Kinetics for the inhibition of Delta10FP2 were very similar to those for FP2 with peptidyl and protein inhibitors, but Delta10FP2 was poorly inhibited by the inhibitory prodomain of FP2. Our results indicate that FP2 utilizes an unusual motif for two specific functions, interaction with hemoglobin, its natural substrate, and interaction with the prodomain, its natural inhibitor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964982      PMCID: PMC1166610          DOI: 10.1073/pnas.0502368102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Hemoglobin metabolism in the malaria parasite Plasmodium falciparum.

Authors:  S E Francis; D J Sullivan; D E Goldberg
Journal:  Annu Rev Microbiol       Date:  1997       Impact factor: 15.500

2.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

Review 3.  Antimalarial drug resistance.

Authors:  Nicholas J White
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

4.  Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.

Authors:  Puran S Sijwali; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

5.  Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.

Authors:  P J Rosenthal; W S Wollish; J T Palmer; D Rasnick
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.

Authors:  P J Rosenthal; G K Lee; R E Smith
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  Targeted disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth.

Authors:  Saliha Eksi; Beata Czesny; Doron C Greenbaum; Matthew Bogyo; Kim C Williamson
Journal:  Mol Microbiol       Date:  2004-07       Impact factor: 3.501

8.  Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

Authors:  W X Tian; C L Tsou
Journal:  Biochemistry       Date:  1982-03-02       Impact factor: 3.162

9.  A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation.

Authors:  Michael Klemba; Ilya Gluzman; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2004-08-10       Impact factor: 5.157

10.  Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition.

Authors:  M G Grütter; J P Priestle; J Rahuel; H Grossenbacher; W Bode; J Hofsteenge; S R Stone
Journal:  EMBO J       Date:  1990-08       Impact factor: 11.598

View more
  28 in total

1.  Substrate mapping and inhibitor profiling of falcipain-2, falcipain-3 and berghepain-2: implications for peptidase anti-malarial drug discovery.

Authors:  Manoj K Ramjee; Nicholas S Flinn; Tracy P Pemberton; Martin Quibell; Yikang Wang; John P Watts
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

2.  Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease.

Authors:  Stephanie X Wang; Kailash C Pandey; John R Somoza; Puran S Sijwali; Tanja Kortemme; Linda S Brinen; Robert J Fletterick; Philip J Rosenthal; James H McKerrow
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

3.  Falcipain-1, a Plasmodium falciparum cysteine protease with vaccine potential.

Authors:  Amit Kumar; Krishan Kumar; Reshma Korde; Sunil Kumar Puri; Pawan Malhotra; Virander Singh Chauhan
Journal:  Infect Immun       Date:  2007-01-22       Impact factor: 3.441

4.  Plasmodium falciparum Falcipain-2a Polymorphisms in Southeast Asia and Their Association With Artemisinin Resistance.

Authors:  Faiza A Siddiqui; Mynthia Cabrera; Meilian Wang; Awtum Brashear; Karen Kemirembe; Zenglei Wang; Jun Miao; Thanat Chookajorn; Zhaoqing Yang; Yaming Cao; Gang Dong; Philip J Rosenthal; Liwang Cui
Journal:  J Infect Dis       Date:  2018-07-02       Impact factor: 5.226

5.  Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum.

Authors:  Monika Chugh; Vidhya Sundararaman; Saravanan Kumar; Vanga S Reddy; Waseem A Siddiqui; Kenneth D Stuart; Pawan Malhotra
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-05       Impact factor: 11.205

6.  Methyl-methoxylpyrrolinone and flavinium nucleus binding signatures on falcipain-2 active site.

Authors:  Olaposi I Omotuyi
Journal:  J Mol Model       Date:  2014-08-06       Impact factor: 1.810

7.  Biochemical properties of a novel cysteine protease of Plasmodium vivax, vivapain-4.

Authors:  Byoung-Kuk Na; Young-An Bae; Young-Gun Zo; Youngchool Choe; Seon-Hee Kim; Prashant V Desai; Mitchell A Avery; Charles S Craik; Tong-Soo Kim; Philip J Rosenthal; Yoon Kong
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12

8.  Vinyl sulfones as antiparasitic agents and a structural basis for drug design.

Authors:  Iain D Kerr; Ji H Lee; Christopher J Farady; Rachael Marion; Mathias Rickert; Mohammed Sajid; Kailash C Pandey; Conor R Caffrey; Jennifer Legac; Elizabeth Hansell; James H McKerrow; Charles S Craik; Philip J Rosenthal; Linda S Brinen
Journal:  J Biol Chem       Date:  2009-07-20       Impact factor: 5.157

9.  Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity.

Authors:  Iain D Kerr; Ji H Lee; Kailash C Pandey; Amanda Harrison; Mohammed Sajid; Philip J Rosenthal; Linda S Brinen
Journal:  J Med Chem       Date:  2009-02-12       Impact factor: 7.446

10.  Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.

Authors:  Shoba Subramanian; Markus Hardt; Youngchool Choe; Richard K Niles; Eric B Johansen; Jennifer Legac; Jiri Gut; Iain D Kerr; Charles S Craik; Philip J Rosenthal
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.